Literature DB >> 26171396

Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System.

Takayuki Ueno1, Jun Utsumi2, Masakazu Toi3, Kazuharu Shimizu4.   

Abstract

The microenvironment of cancer cells has been implicated in cancer development and progression. Cancer-associated fibroblast constitutes a major stromal component of the microenvironment. To analyze interaction between cancer cells and fibroblasts, we have developed a new bilateral coculture system using a two-sided microporous collagen membrane. Human normal skin fibroblasts were cocultured with three different human breast cancer cell lines: MCF-7, SK-BR-3, and HCC1937. After coculture, mRNA was extracted separately from cancer cells and fibroblasts and applied to transcriptomic analysis with microarray. Top 500 commonly up- or downregulated genes were characterized by enrichment functional analysis using MetaCore Functional Analysis. Most of the genes upregulated in cancer cells were downregulated in fibroblasts while most of the genes downregulated in cancer cells were upregulated in fibroblasts, indicating that changing patterns of mRNA expression were reciprocal between cancer cells and fibroblasts. In coculture, breast cancer cells commonly increased genes related to mitotic response and TCA pathway while fibroblasts increased genes related to carbohydrate metabolism including glycolysis, glycogenesis, and glucose transport, indicating that fibroblasts support cancer cell proliferation by supplying energy sources. We propose that the bilateral coculture system using collagen membrane is useful to study interactions between cancer cells and stromal cells by mimicking in vivo tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26171396      PMCID: PMC4480803          DOI: 10.1155/2015/960840

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

The microenvironment of cancer cells has been suggested to play critical roles in cancer development, progression, and therapeutic response. Cancer cells are supported by surrounding stromal cells such as fibroblasts, macrophages, myoblasts, and endothelial cells [1]. Fibroblasts that surround and interact with cancer cells have been called cancer-associated fibroblasts (CAFs) which can exert unique roles to support cancer cell growth [1]. These supporting effects via cell-cell cross talk may be different according to cancer cell types and characteristics, which remains to be elucidated. To analyze cell-cell cross talk in vitro, several types of in vitro coculture systems such as a direct physical contact, an interaction coculture, and a transwell system have been developed [2-6]. In a direct contact, two types of cells are grown together in physical contact whereas, in an interaction coculture, two cell types are grown separated by a membrane and contact via soluble factors [7]. In a transwell system, one type of cells is grown on microporous membranes inserted in culture vessels where the other cell type is grown on the bottom and they communicate via soluble factors. These methods are useful to analyze cell-cell cross talk between tumor and nontumor cells in a single culture system. However, the organization of tumor and nontumor cells is different from in vivo conditions where tumor cells and stromal cells communicate through extracellular matrix such as collagen, neither through conditioned media nor by direct contact. Recently, a micropatterned coculture system has been introduced [8]. Epithelial cells are cultured on circular spots of extracellular matrix and subsequently stromal cells are seeded in the space between spots [8]. This system allows for an organized culture condition where epithelial cells on extracellular matrix are surrounded by stromal cells, which is similar to an in vivo condition. However, epithelial cells communicate with stromal cells through direct contact or soluble factors but not through extracellular matrix. Here we have developed a novel bilateral coculture system in vitro to resemble in vivo conditions of cancer and stromal cells with extracellular matrix. By using three different subtypes of breast cancer cell lines and normal fibroblasts, we examined the interaction between cancer cells and fibroblasts and analyzed changes in gene expressions of both cancer cells and fibroblast to study a cross talk between cancer cells and stromal cells.

2. Materials and Methods

2.1. Cell Culture System

A suspending two-sided microporous collagen membrane with polystyrene reinforced outer frame (AteloCell, Koken Co. Ltd., Tokyo) was positioned in the culture medium in 50 mm diameter culture vessel. Normal human dermal fibroblasts (NHDF (NB) cells, Kurabo Industries Ltd., Osaka) were cocultured with one of the three different human breast cancer cell lines (luminal MCF-7, HER2-positive SK-BR-3, and triple-negative HCC1937) in this system. Normal human dermal fibroblasts were cultured on the lower side of collagen membrane (6 cm dish, 10% fetal bovine serum (FBS)/Dulbecco's modified essential medium (DMEM) for 1 day) and then breast cancer cells were inoculated and cultured on the upper side to form bilateral coculture (in 6 cm dish, 10% FBS/DMEM, 37°C for 3 days). For cross talk conditions, cancer cells (upper side) and fibroblasts (lower side) were cocultured in this system. For control conditions, the same cells were cultured on both sides of the bilateral membrane such as fibroblasts (upper side) and fibroblasts (lower side) or cancer cells (upper side) and cancer cell (lower side). Both sides of cells are able to interact through the collagen membrane and conditioned medium via secreted mediators.

2.2. Microscopic Observation

To confirm the condition of bilateral coculture with microscopic observation, collagen membrane after coculture for 3 days was collected and washed with phosphate buffered saline (PBS) (pH 7.4) twice and fixed with formalin/PBS and stained with haematoxylin and eosin. For electron microscopy, an ultrathin section from duplicated membrane specimen was produced by an ultramicrotome (DiATOME Ultra45°) and stained with uranyl acetate followed by aqueous lead citrate.

2.3. Transcriptomic Analysis

To analyze cell-cell interaction between two cell populations, each population must be separately collected after cellular cross talk. The primary aim of our coculture system is to harvest independently each side of cell population after coculture to study the cross talk between normal cell and cancer cell. After coculture for 3 days, cells were collected from the collagen membrane and applied to transcriptomic profile analysis of cultured cells. mRNA was extracted from cells with QIAzol Lysis Reagent (QIAGEN, Hilden). Harvested mRNA was applied to transcriptomic analysis with the highly sensitive microarray (3D-gene DNA tip, Toray Industries, Inc., Tokyo) [9] according to the manufacture's instruction for one-color analysis.

2.4. Bioinformatics Analysis

From the resulting list of expression genes, top 500 upregulated and downregulated genes were selected. These top 500 genes were applied to bioinformatics analysis to annotate gene function. Top 500 genes from upregulated and downregulated gene lists were applied to the web-based bioinformatics tool of MetaCore Functional Analysis (Thomson Reuter/GeneGo) on ontology, molecular pathway, and enrichment functional analyses to estimate canonical biological responses. The gene ontology (GO) analysis provides gene function and network of expressed gene through the cell-cell cross talk with breast cancer cells and fibroblasts.

3. Results

We have developed a bilateral coculture system to evaluate cell-cell cross talk by using collagen matrix membrane as shown in the experimental procedure in Figure 1. Two-sided collagen membrane was suspended by polystyrene reinforced outer frame in the culture medium. Breast cancer cells and fibroblasts were separately cultured on each side of the collagen membrane which played a role of extracellular matrix. The collagen membrane is composed of microporous matrix structure with the thickness of 20 micrometers and pores of less than 1-micrometer diameter to prevent cell migration into the membrane. The cancer cells and fibroblasts interact via soluble mediators through membrane and outer culture medium.
Figure 1

A concept view of bilateral coculture system and flow of experimental procedures. Breast cancer cells and fibroblasts were cocultured on each side of the bilateral microporous collagen matrix membrane. A suspending two-sided microporous collagen membrane with polystyrene reinforced outer frame was positioned in the culture medium in 50 mm diameter culture vessel. Cells were cultured as shown in the microscopic photo. Analytical flow is as illustrated by employing transcriptomic and bioinformatics analyses.

We examined the morphological change of cocultured cells in this system by electron microscope. As shown in Figure 2, the cellular morphology and intracellular structures of cells in coculture were compared with those in the control condition. The control condition was the culture with the same cells on both sides, such as combinations of fibroblasts with fibroblasts or cancer cells with cancer cells. In the coculture of fibroblasts and cancer cells, HCC1937 cells showed a little round shape similar to that observed at mitotic phase, whereas fibroblasts showed a slim and waste shape with intracellular vacuole-like structures.
Figure 2

Electron microscopic views of cells in coculture. (a) Fibroblasts were cocultured with HCC1937 breast cancer cells (lower photo). As a control, fibroblasts were cultured with fibroblasts (upper photo). In coculture with HCC1937 cells, morphological change of cellular body shape and vacuole-like spaces were observed. (b) HCC1937 breast cancer cells were cocultured with fibroblasts (lower photo). As a control, HCC1937 cells were cultured with HCC1937 cells (upper photo). By coculture with fibroblasts, morphological changes of round shape were observed. Optical microscopic photos were shown at the top right corner.

After 3 days of coculture, cells were independently collected from each side of the membrane and mRNA was extracted and applied to transcriptomic analysis. Figure 3(a) showed an upregulated gene expression profile of mRNA from cocultured HCC1937 breast cancer cells compared with control HCC 1937 cells (red bar) and alterations in expression of corresponding genes in cocultured fibroblasts compared with control fibroblast (blue bar). Interestingly, most of the genes upregulated in HCC1937 cancer cells were downregulated in fibroblasts and thus changing patterns of mRNA expression seemed to be reciprocal between HCC1937 cells and fibroblasts, suggesting that HCC1937 cells and counterpart fibroblasts exert distinct functions by interacting with each other. Among top 100 upregulated genes in HCC1937 cells, 77% of genes were downregulated in fibroblasts.
Figure 3

Alteration in individual gene expression in HCC1937 cells and fibroblasts in coculture. (a) Upregulated gene expression profile of mRNA in cocultured HCC1937 breast cancer cells and changes of corresponding genes in fibroblasts. (b) Downregulated gene expression profile of mRNA in cocultured HCC1937 breast cancer cells and changes of corresponding genes in fibroblasts.

Figure 3(b) showed a downregulated gene expression profile of mRNA of cocultured HCC1937 breast cancer cells (red bar) with alterations in corresponding genes of cocultured fibroblasts (blue bar). Like upregulated genes, changes in most genes seemed to be reciprocal between HCC1937 cells and counterpart fibroblasts in the coculture condition. Among top 100 downregulated genes of HCC1937 cells, 82% of the genes were upregulated in fibroblasts. Gene ontology analysis revealed that HCC1937 cells showed an increase in mitosis-associated genes and carbohydrate metabolic process (Table 1), suggesting that HCC1937 cells received proliferation stimulus through coculture with fibroblasts, which is consistent with the morphological changes observed in Figure 2. SKBR3 and MCF7 cells cocultured with fibroblasts also upregulated genes associated with cellular activity as shown in Table 1.
Table 1

Enrichment analysis: upregulation in each cancer cell line.

#Upregulation: GO processes in MCF7 p valueFDR
1Cellular process2.840E − 078.455E − 04
2Protein localization to cell junction1.219E − 061.814E − 03
3Regulation of cardiac muscle cell apoptotic process2.189E − 062.172E − 03

#Upregulation: GO processes in SKBR3 p valueFDR

1Cell cycle1.192E − 093.578E − 06
2Apoptotic process5.228E − 094.644E − 06
3Cellular metabolic process6.045E − 094.644E − 06

#Upregulation: GO processes in HCC1937 p valueFDR

1Nuclear division1.054E − 122.428E − 09
2Organelle fission2.879E − 123.317E − 09
3Cell division1.106E − 118.495E − 09

#Upregulation: metabolic networks in MCF7 p valueFDR

1Carbohydrate metabolism_TCA and tricarboxylic acids transport6.670E − 033.936E − 01
2Carbohydrate metabolism_propionate metabolism and transport7.222E − 033.936E − 01
3Vitamin, mediator, and cofactor metabolism_folic acid1.949E − 024.310E − 01

#Upregulation: metabolic networks in SKBR3 p valueFDR

11-Hexadecanoyl-glycerol_3-phosphate pathway7.085E − 074.411E − 05
21-Linoleoyl-glycerol_3-phosphate pathway1.357E − 064.411E − 05
31-Oleoyl-glycerol_3-phosphate pathway1.030E − 052.231E − 04

#Upregulation: metabolic networks in HCC1937 p valueFDR

1Carbohydrate metabolism_pyruvate metabolism and transport6.259E − 032.072E − 01
2Lipid metabolism_triacylglycerol metabolism1.271E − 022.072E − 01
3N-Acetyl-D-galactosamine pathway6.763E − 022.072E − 01
According to gene ontology analysis, HCC1937 cells showed a decrease in acute inflammatory response genes and phospholipid metabolic process (Table 2). SKBR3 and MCF7 cells cocultured with fibroblasts also downregulated genes associated with cellular transport as shown in Table 2.
Table 2

Enrichment analysis: downregulation in each cancer cell line.

#Downregulation: GO processes in MCF7 p valueFDR
1Establishment of localization2.679E − 052.740E − 02
2Transport3.991E − 052.740E − 02
3Peptidylglycine modification6.089E − 052.740E − 02

#Downregulation: GO processes in SKBR3 p valueFDR

1Regulation of apoptotic process1.195E − 121.799E − 09
2Regulation of programmed cell death1.578E − 121.799E − 09
3Response to mechanical stimulus1.664E − 121.799E − 09

#Downregulation: GO processes in HCC1937 p valueFDR

1Acute inflammatory response9.865E − 192.218E − 15
2Response to metal ion1.618E − 121.818E − 09
3Response to inorganic substance2.566E − 121.923E − 09

#Downregulation: metabolic networks in MCF7 p valueFDR

1Lysophosphatidylserine pathway8.304E − 042.574E − 02
2Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport3.844E − 035.958E − 02
31,2-Didocosapentaenoyl-sn-glycerol_3-phosphate pathway1.913E − 021.158E − 01

#Downregulation: metabolic networks in SKBR3 p valueFDR

1GalNAcbeta1-3Gal pathway5.291E − 043.122E − 02
2Pentose phosphate pathways and transport1.247E − 033.677E − 02
3(L)-Alanine pathways and transport9.059E − 031.782E − 01

#Downregulation: metabolic networks in HCC1937 p valueFDR

1Phosphatidylethanolamine pathway5.054E − 055.559E − 03
2O-Hexanoyl-(L)-carnitine pathway5.897E − 042.359E − 02
3Myristoyl-L-carnitine pathway6.435E − 042.359E − 02
Similar enrichment analyses were performed for fibroblasts cocultured with cancer cells (Tables 3 and 4). The analyses showed that genes associated with cell death regulation, stress, hypoxia, and carbohydrate metabolism were upregulated in fibroblasts. These results seemed to indicate that cocultured fibroblasts provided beneficial effects for cancer cells for survival and proliferation. In fibroblasts, genes associated with cell mitosis and cell membrane components synthetic pathways were downregulated (Table 4).
Table 3

Enrichment analysis: upregulation in fibroblasts.

#Upregulation: GO processes with MCF7 p valueFDR
1Regulation of programmed cell death1.104E − 153.326E − 12
2Regulation of cell death5.311E − 158.004E − 12
3Regulation of apoptotic process3.070E − 143.085E − 11

#Upregulation: GO processes with SKBR3 p valueFDR

1Cellular component organization8.231E − 112.156E − 07
2Cellular component organization or biogenesis2.519E − 103.299E − 07
3Response to stress3.864E − 073.373E − 04

#Upregulation: GO processes with HCC1937 p valueFDR

1Single-organism cellular process2.687E − 114.223E − 08
2Single-organism process2.848E − 114.223E − 08
3Response to hypoxia6.596E − 114.909E − 08

#Upregulation: metabolic networks with MCF7 p valueFDR

1(S)-Citrulline pathway1.930E − 042.277E − 02
2Glycine pathways and transport1.052E − 036.208E − 02
3L-Serine pathways and transport1.889E − 037.432E − 02

#Upregulation: metabolic networks with SKBR3 p valueFDR

1Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport1.938E − 064.456E − 05
2Carbohydrate metabolism_fructose metabolism and transport7.287E − 048.380E − 03
3(L)-Alanine pathways and transport1.295E − 027.443E − 02

#Upregulation: metabolic networks with HCC1937 p valueFDR

1Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport4.800E − 082.112E − 06
2Carbohydrate metabolism_fructose metabolism and transport3.818E − 068.400E − 05
3Carbohydrate metabolism_galactose metabolism and transport4.798E − 057.037E − 04
Table 4

Enrichment analysis: downregulation in fibroblasts.

#Downregulation: GO processes with MCF7 p valueFDR
1Mitotic cell cycle5.614E − 481.698E − 44
2Cell cycle7.592E − 441.148E − 40
3Mitotic cell cycle process3.015E − 423.040E − 39

#Downregulation: GO processes with SKBR3 p valueFDR

1Regulation of lipid metabolic process1.373E − 135.965E − 10
2Positive regulation of biological process8.382E − 121.820E − 08
3Regulation of protein metabolic process1.294E − 111.874E − 08

#Downregulation: GO processes with HCC1937 p valueFDR

1Translation2.041E − 091.903E − 06
2Cellular macromolecular complex assembly2.157E − 091.903E − 06
3Nuclear-transcribed mRNA catabolic process2.488E − 081.313E − 05

#Downregulation: metabolic networks with MCF7 p valueFDR

12-Oleoyl-glycerol_3-phosphate pathway2.569E − 041.079E − 02
2Lysophosphatidic acid pathway7.980E − 041.676E − 02
31-Hexadecanoyl-glycerol_3-phosphate pathway1.298E − 031.818E − 02

#Downregulation: metabolic networks with SKBR3 p valueFDR

1N-Acyl-sphingosine phosphate pathway3.589E − 082.441E − 06
21,2-Didocosapentaenoyl-sn-glycerol_3-phosphate pathway1.119E − 042.836E − 03
31,2-Dioleoyl-sn-glycerol_3-phosphate pathway1.373E − 042.836E − 03

#Downregulation: metabolic networks with HCC1937 p valueFDR

1Amino acid metabolism_lysine metabolism and transport5.363E − 031.634E − 01
2Carbohydrate metabolism_pyruvate metabolism and transport1.318E − 021.634E − 01
3Glucosylceramide pathways and transport1.905E − 021.634E − 01
To understand general events in cancer cell-fibroblast cross talk, commonly changed genes were extracted among three types of breast cancer cells cocultured with fibroblasts. Similarly, commonly changed genes in fibroblasts cocultured with three different types of breast cancer cell lines were extracted. To mine the common genes either upregulated or downregulated in cocultured cells, top 500 genes were annotated. Tables 5(a) and 5(b) show gene ontology biological process and metabolic network with the specific gene names. As shown in Table 5(a), the prominent upregulation was observed in genes associated with cell cycle and cell division. Breast cancer cells also showed an increase in genes associated with carbohydrate metabolism, TCA, and amino acid metabolism, while functional process, phosphatides acid pathway, and glucuronic acid pathway were downregulated in three cancer cell lines (Table 5(b)). The top 30 genes of altered expression in each of the three different cancer cell lines were listed in Table 5(c). No commonly upregulated genes among three cancer cell lines were observed. However, a transcriptional coactivator complex subunit, mediator complex subunit 13 (MED13), a regulator of cell proliferation, differentiation, and transformation, FBJ murine osteosarcoma viral oncogene homolog (FOS), and nuclear protein, transcriptional regulator, 1 (NUPR1) were commonly downregulated in top 30 genes. The enrichment analysis also revealed that commonly upregulated genes in fibroblasts were associated with single-organism cellular process, carbohydrate transport, and amino acid transport as shown in Table 6(a). Furthermore, commonly downregulated genes in fibroblasts were genes associated with immune response regulation, cholesterol biosynthesis, and lipid metabolism (Table 6(b)).

4. Discussion

In the present study, we have developed a new bilateral coculture system to evaluate cell-cell cross talk by using collagen matrix membrane. The membrane is made of microporous collagen sheet with thickness of 20 micrometers and pore of less than 1-micrometer diameter. Cells do not penetrate into the membrane but interact with each other via secreted soluble factors such as metabolites, cytokines, and exosomes. One of the technical advantages of this system is the coculture of different cells on each side of the collagen membrane, which resembles in vivo conditions as extracellular matrix between cancer cells and stromal cells. In addition, this system enables retaining cellular polarity and, thus, stromal cells interact with “basal” sides of cancer cells through collagen, which is also in line with in vivo conditions. Even if cancer cells, especially poorly differentiated cancer cells, lose polarity, cancer cells communicate with stromal cells mostly via extracellular matrix, which can be mimicked by this system. Our system consists of not only the culture system but also the following procedures and data analyses. Our total system is as follows: different cells were cultured on each side of the bilateral membrane and separately harvested followed by mRNA extraction, transcriptome, and bioinformatics analyses. To optimize these procedures, we chose the bilateral microporous collagen membrane but not polystyrene and polysulfone based membranes. We found that, in fibroblasts cocultured with breast cancer cells, genes associated with carbohydrate metabolism including glycolysis, glycogenesis, and glucose transport were upregulated while, in cancer cells, genes associated with the tricarboxylic acid (TCA) cycle were upregulated. Our result is in agreement with the study by Fiaschi et al. showing that, through tumor-stromal interplay, cancer cells were reprogrammed toward aerobic metabolism while CAFs were reprogrammed toward a Warburg phenotype [10]. They suggested that cancer cells develop a dependence on lactate produced by CAFs for their growth, which is assumed to be an adaptation strategy to a low glucose environment [10]. Thus, it is conceivable that targeting not only cancer cells but also stromal cells is necessary for successful anticancer treatment, especially treatment regulating metabolic processes. Altered expression of genes in hypoxic response and cancer invasion were observed in the present analysis. Hypoxia inducible factor 1, alpha subunit (HIF1A) was downregulated in common in cancer cells (Table 5(b)), while stromelysin-1 (matrix metallopeptidase 3), vascular endothelial growth factor A (VEGF-A), and neuropilin-1 were upregulated in common in fibroblasts (Table 6(a)). These responses suggested that CAFs play a supportive role of cancer cell invasion via tissue remodeling and neovascularization. In fibroblasts, genes associated with cell death regulation, stress, hypoxia, and carbohydrate metabolism were upregulated. On the other hand, genes associated with cell mitosis and cell membrane components synthetic pathways were downregulated in fibroblasts. These results suggest that CAFs play roles to support cancer cells in multiple ways for survival and proliferation. There are several reports studying coculture with cancer cells and fibroblasts. In the study by Camp et al. where a direct coculture and a transwell system were applied, luminal type cancer cells behaved differently from basal-like cancer cells when cocultured with fibroblasts [7]. Luminal type cancer cells upregulated proliferation-related processes while basal-like cancer cells increased cellular migration in the coculture. Similarly, Rozenchan et al. showed, by using a transwell system, a basal-like cell line MDA-MB231 increased motility-associated genes [11]. In our system, genes associated with cell cycle or mitosis were commonly upregulated in breast cancer cell lines, which is in concordance with the previous reports. Interestingly, basal-like cell line HCC1937 increased genes associated with cellular division rather than migration in our system. Since rapid proliferation of cancer cells is a key feature of basal-like breast cancers, our system reflected an important aspect in “in vivo” conditions of basal-like breast cancer cells. We believe that the coculture system to better mimic in vivo conditions is of great value for analysis of interaction between cancer cells and stromal cells. One possible application of our coculture system will be a drug screening. High-throughput drug screening is a key process for discovery and efficient development of new compounds for anticancer therapy [12, 13]. Screening with monoculture system has a limitation in that tumor-stromal interaction cannot be assessed although stromal components in tumor tissues play pivotal roles in response to anticancer agents. The bilateral coculture system in the present study would provide a useful system for such a purpose for drug development. In conclusion, we developed a bilateral coculture system and showed that, in the coculture, breast cancer cells increased mitotic response and TCA pathway while fibroblasts increased carbohydrate metabolism including glycolysis, glycogenesis, and glucose transport, which is consistent with the notion that CAFs support cancer cell proliferation by providing energy sources. We propose that the bilateral coculture system using collagen membrane is useful to study interactions between cancer and stromal cells and would help effective drug screening by mimicking in vivo tumor microenvironment.
(a)
#Upregulation: GO processes in common of MCF7, SKBR3, and HCC1937 (104 genes) p valueFDR
1Cell cycle1.002E − 222.262E − 19
D53, CDC18L (CDC6), ECT2, MCM7, Bard1, Thymidylate kinase, TTK, Rabkinesin-6, VRK1, HDAC1, TIPIN, CDC20, Histone deacetylase class I, DCC1, RFC4, ORC6L, CD2AP, EXO1, and BORIS

2Mitotic cell cycle8.624E − 229.732E − 19
D53, CDC18L (CDC6), MCM7, TTK, Rabkinesin-6, VRK1, HDAC1, TIPIN, CDC20, Histone deacetylase class I, DCC1, RFC4, ORC6L, CD2AP, C15orf23, HSP70, MAD2a, PBK, and TOP2 alpha

3Cell cycle process1.898E − 191.428E − 16
D53, CDC18L (CDC6), ECT2, MCM7, Bard1, TTK, Rabkinesin-6, VRK1, TIPIN, CDC20, Histone deacetylase class I, DCC1, RFC4, ORC6L, CD2AP, C15orf23, HSP70, MAD2a, PBK, and TOP2 alpha

4Mitotic cell cycle process4.502E − 182.540E − 15
D53, CDC18L (CDC6), MCM7, TTK, VRK1, TIPIN, CDC20, DCC1, ORC6L, CD2AP, C15orf23, HSP70, MAD2a, PBK, TOP2 alpha, Tubulin alpha, RRS1, Aurora-A, MSH2, CDK inhibitor 3, CKS1, and Tome-1

5Cell division2.367E − 161.068E − 13
CDC18L (CDC6), ECT2, Rabkinesin-6, VRK1, TIPIN, CDC20, DCC1, CD2AP, EXO1, C15orf23, HSP70, MAD2a, PBK, TOP2 alpha, Tubulin alpha, RRS1, Aurora-A, MSH2, CKS1, Tome-1, and CCAR1

#Upregulation: metabolic networks in common of MCF7, SKBR3, and HCC1937 (104 genes) p valueFDR

1Carbohydrate metabolism_TCA and tricarboxylic acids transport3.939E − 037.900E − 02
ODO2, SLC25A21, and SUCB1

2Carbohydrate metabolism_propionate metabolism and transport4.270E − 037.900E − 02
ACAT2, ACYP1, and SUCB1

3Amino acid metabolism_lysine metabolism and transport8.343E − 031.029E − 01
ODO2, ACAT2

4Phosphatidylcholine pathway2.664E − 021.764E − 01
HSP70, COASY

51,2-Didocosapentaenoyl-sn-glycerol_3-phosphate pathway3.305E − 021.764E − 01
AP3D1, Tubulin alpha
(b)
#Downregulation: GO processes in common of MCF7, SKBR3, and HCC1937 (105 genes) p valueFDR

1Negative regulation of vasoconstriction1.343E − 061.091E − 03
HSPA1A, HSPA1B, HSP70, and HIF1A

2Positive regulation of erythrocyte differentiation1.876E − 061.143E − 03
HSPA1A, HSPA1B, ID2, HSP70, and HIF1A

3Response to mechanical stimulus2.787E − 061.358E − 03
ITGB1, EGR1, KV1.5, JunB, HSPA1A, HSPA1B, p70 S6 kinases, HSP70, c-Fos, ASNS, and HIF1A

4Response to radiation5.797E − 062.355E − 03
AKR1C4, ITGB1, EGR1, AKR1C1, Catalase, JunB, HSPA1A, HSPA1B, HSP70, PUMA, DEC1 (Stra13), USP47, c-Fos, ASNS, and HIF1A

5Protein refolding6.979E − 062.430E − 03
HSPA1A, HSPA1B, ST13 (Hip), and HSP70

#Downregulation: metabolic networks in common of MCF7, SKBR3, and HCC1937 (105 genes) p valueFDR

1Phosphatides acid pathway1.438E − 031.093E − 01
PPAP2, LPP3

2D-Glucuronic acid pathway3.958E − 031.504E − 01
AKR1C4, TBP, and c-Fos

3Steroid metabolism_pregnenolone and progesterone metabolism1.201E − 023.043E − 01
AKR1C4, HSD17B8, and AKR1C2

42-Arachidonoylglycerol_3-phosphocholine pathway2.337E − 024.434E − 01
Tissue kallikreins, Prostasin, and HIF1A

5(L)-Leucine pathways and transport5.754E − 024.434E − 01
p70 S6 kinase2, OSCP1
(c)
Upregulated genesDownregulated genes
MCF7SKBR3HCC1937MCF7SKBR3HCC1937
IFIT1PTGS1BUB1STK19DUSP1SCGB1A1
AP1B1CTSZCDCA8HMOX1 FOS TF
OATCYP1B1C13orf34MEIS3EGR1C20orf114
ECT2ALDH3B2ABHD10NMT1SYCE1LYNX1
EFNA1SFRS16NSMAFCRK NUPR1 CLCA2
TMEM189-UBE2V1BPNT1KIF2CDIABLONR4A2CASP14
AMHSLC39A7SREBF2WDR34ENDOD1CP
NFE2L2ATF1SLC20A1D2HGDHNR4A1EGLN3
PDPK1A4GNTEBNA1BP2ATP1B1OR14K1C7orf29
HSPA8BLZF1NCAPHTIMM50ATF4MATN2
ZNF117TUBA3CTFPI2TMEM183AIFI6SERPINA3
GM2AEXO1PHLDA1GDI1BAK1TNFSF10
NUF2ST3GAL4ATP6V1C1TMEM168ASNSTMC4
ANP32ACSNK2A1DDX47COX7BSCNM1ANGPTL4
ACYP1CARHSP1ODC1AIFM2TPM4LY6D
RCN2C13orf37VEGFCNUP188MXD1S100A8
STX3TRAF4GTF2BDUSP22ACTA1CHI3L2
TSSC1C4orf43SLC10A3MAK16CTGFKRT15
HEBP1DCTPP1ALDH7A1TROAP MED13 PSCA
FAM132ACCAR1CDC45LC19orf46ZNF783SELENBP1
TMED10BAXFUBP1 MED13 CXorf23 NUPR1
KTN1DSCC1GS1-484O17.2CLDN4ADMANKRD37
ACTR6YWHAGCCT8SLC25A1SREBF2CLDN8
AURKATEX261MESTARF1ID1FBXO32
NGRNS100A9NCAPGPHF2ZG16PLXND1
ILKFAM10A5MKI67FFAR3RGS16SERPINA5
STAT1FKBP10KIAA0101SCAF1CLIC4 FOS
PWP1ACO2SUB1C2orf76MED12NDRG1
PABPC3TMSB4XKIAA1524MYOM2JUNCRIP2
SLBPVWA5B1FGF2KCTD17RNF126WFDC2
(a)
#Upregulation: GO processes in common versus MCF7, SKBR3, and HCC1937 (130 genes) p valueFDR
1Single-organism cellular process1.586E − 104.679E − 07
SMURF, FTS, ATF-4, AP-3 sigma subunits, SAT-1, Tenascin-C, GLSL, COUP-TFII, GCR-beta, SLIT2, SLFN5, TRUNDD(TNFRSF10D), MCT1 (SLC16A1), Neuropilin-1, RRN3, GLSK, SMAD6, FoxD1, and NIP3

2Response to organic cyclic compound3.170E − 104.679E − 07
Tenascin-C, COUP-TFII, GCR-beta, SLIT2, MCT1 (SLC16A1), SMAD6, TIMP3, MKP-3, MKP-1, Lysyl oxidase, Adipophilin, COUP-TFI, Stromelysin-1, SLIT3, Stanniocalcin 2, and VEGF-A

3Single-organism process7.615E − 106.297E − 07
SMURF, FTS, MOXD1, ATF-4, AP-3 sigma subunits, SAT-1, Tenascin-C, GLSL, COUP-TFII, GCR-beta, SLIT2, SLFN5, TRUNDD(TNFRSF10D), MCT1 (SLC16A1), Neuropilin-1, RRN3, GLSK, SMAD6, and TIMP3

4Response to endogenous stimulus8.532E − 106.297E − 07
SMURF, AP-3 sigma subunits, Tenascin-C, COUP-TFII, GCR-beta, SLIT2, SMAD6, TIMP3, PINCH, Connexin 43, SMURF2, GCR-alpha, PDGF-C, MKP-1, Lysyl oxidase, Stromelysin-1, SLIT3, and VEGF-A

5Organic anion transport2.208E − 091.304E − 06
SAT-1, GLSL, MCT1 (SLC16A1), GLSK, MCT4, CAT-1 (SLC7A1), Connexin 43, GLUT3, Adipophilin, SLC25A4, SLC38A1, Carbonic anhydrase XII, SLC38A2, SLC27A3, CAT-3, SLC7A5, and ANT

#Upregulation: metabolic networks in common versus MCF7, SKBR3, and HCC1937 (130 genes) p valueFDR

1Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport9.568E − 064.497E − 04
PFKP, GLUT3, ALDOC, ENO2, ALDOA, and ENO

2Carbohydrate metabolism_sucrose metabolism and transport4.596E − 057.525E − 04
COUP-TFII, GLUT3, COUP-TFI, Glycogen phosphorylase, and PYGL

3(L)-Proline pathways and transport4.803E − 057.525E − 04
CAT-1 (SLC7A1), Glycogen phosphorylase, SLC38A2, CAT-3, SLC7A5

4L-Serine pathways and transport1.369E − 041.538E − 03
CAT-1 (SLC7A1), SLC38A1, SLC38A2, CAT-3, and SLC7A5

5(S)-Citrulline pathway1.636E − 041.538E − 03
CAT-1 (SLC7A1), Glycogen phosphorylase, CAT-3, and SLC7A5
(b)
#Downregulation: GO processes in common versus MCF7, SKBR3, and HCC1937 (107 genes) p valueFDR

1Response to organic substance1.120E − 103.750E − 07
ERG1, IDI1, HSBP3, Ribonucleotide reductase, Galpha(s)-specific prostanoid GPCRs, MGMT, Cathepsin S, GREM2, MMP-13, SFRS3, BMP2, H-FABP, ACAT2, MGST3, IBP2, NNMT, CCL2, and DNAJA3

2Regulation of immune complex clearance by monocytes and macrophages4.480E − 094.999E − 06
CCL2, CCL13, Galpha(q)-specific peptide GPCRs, Galpha(i)-specific peptide GPCRs

3Positive regulation of immune complex clearance by monocytes and macrophages4.480E − 094.999E − 06
CCL2, CCL13, Galpha(q)-specific peptide GPCRs, and Galpha(i)-specific peptide GPCRs

4Response to endogenous stimulus1.450E − 081.213E − 05
Ribonucleotide reductase, Galpha(s)-specific prostanoid GPCRs, MGMT, Cathepsin S, MMP-13, SFRS3, BMP2, H-FABP, MGST3, IBP2, NNMT, CCL2, CCL13, and Galpha(q)-specific peptide GPCRs

5Response to acid2.446E − 081.638E − 05
Galpha(s)-specific prostanoid GPCRs, MGMT, BMP2, H-FABP, ACAT2, IBP2, CCL2, CCL13, Galpha(q)-specific peptide GPCRs, Galpha(i)-specific peptide GPCRs, PGD2R, PEDF (serpinF1), INSIG1, and CD9

#Downregulation: metabolic networks in common versus MCF7, SKBR3, and HCC1937 (107 genes) p valueFDR

1Steroid metabolism_cholesterol biosynthesis3.670E − 061.468E − 04
ERG1, IDI1, ACAT2, DHC24, MVD, and DHCR7

2GalNAcbeta1-3Gal pathway5.291E − 041.058E − 02
Coagulation factor X, Galpha(q)-specific peptide GPCRs, Galpha(i)-specific peptide GPCRs, and CD13

3N-Acyl-sphingosine phosphate pathway8.346E − 031.113E − 01
Galpha(q)-specific peptide GPCRs, PLAU (UPA), and MMP-1

4Lipid metabolism_n-6 polyunsaturated fatty acid biosynthesis3.289E − 023.270E − 01
FADS2, FADS1

5Glucosylceramide pathways and transport5.067E − 023.270E − 01
FADS2, FADS1
  13 in total

1.  Microscale culture of human liver cells for drug development.

Authors:  Salman R Khetani; Sangeeta N Bhatia
Journal:  Nat Biotechnol       Date:  2007-11-18       Impact factor: 54.908

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.

Authors:  Suling Liu; Christophe Ginestier; Sing J Ou; Shawn G Clouthier; Shivani H Patel; Florence Monville; Hasan Korkaya; Amber Heath; Julie Dutcher; Celina G Kleer; Younghun Jung; Gabriela Dontu; Russell Taichman; Max S Wicha
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

4.  Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers.

Authors:  J Terese Camp; Fathi Elloumi; Erick Roman-Perez; Jessica Rein; Delisha A Stewart; J Chuck Harrell; Charles M Perou; Melissa A Troester
Journal:  Mol Cancer Res       Date:  2010-12-03       Impact factor: 5.852

5.  A novel high-through-put assay for screening of pro-apoptotic drugs.

Authors:  Maria Hägg; Kenneth Bivén; Takayuki Ueno; Lars Rydlander; Peter Björklund; Klas G Wiman; Maria Shoshan; Stig Linder
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

6.  Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts.

Authors:  Patricia Bortman Rozenchan; Dirce Maria Carraro; Helena Brentani; Louise Danielle de Carvalho Mota; Elen Pereira Bastos; Elisa Napolitano e Ferreira; Cesar H Torres; Maria Lúcia Hirata Katayama; Rosimeire Aparecida Roela; Eduardo C Lyra; Fernando Augusto Soares; Maria Aparecida Azevedo Koike Folgueira; João Carlos Guedes Sampaio Góes; Maria Mitzi Brentani
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

7.  Identification of AhR-regulated genes involved in PAH-induced immunotoxicity using a highly-sensitive DNA chip, 3D-Gene Human Immunity and Metabolic Syndrome 9k.

Authors:  Shunsuke Iwano; Makiko Ichikawa; Satoko Takizawa; Hisashi Hashimoto; Yohei Miyamoto
Journal:  Toxicol In Vitro       Date:  2009-09-06       Impact factor: 3.500

8.  Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.

Authors:  Martin Buess; Michal Rajski; Brigitte M L Vogel-Durrer; Richard Herrmann; Christoph Rochlitz
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

Review 9.  Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma.

Authors:  Patricia Casbas-Hernandez; Jodie M Fleming; Melissa A Troester
Journal:  J Biomed Biotechnol       Date:  2011-12-13

10.  Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer.

Authors:  Martin Buess; Dimitry S A Nuyten; Trevor Hastie; Torsten Nielsen; Robert Pesich; Patrick O Brown
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  7 in total

1.  Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments.

Authors:  Mary C Regier; Lindsey J Maccoux; Emma M Weinberger; Keil J Regehr; Scott M Berry; David J Beebe; Elaine T Alarid
Journal:  Biomed Microdevices       Date:  2016-08       Impact factor: 2.838

Review 2.  Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance.

Authors:  Adele Chimento; Maria D'Amico; Vincenzo Pezzi; Francesca De Amicis
Journal:  Int J Mol Sci       Date:  2022-06-04       Impact factor: 6.208

Review 3.  The diverse role of oral fibroblasts in normal and disease.

Authors:  R J Vijayashree; B Sivapathasundharam
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

4.  Heterotypic breast cancer model based on a silk fibroin scaffold to study the tumor microenvironment.

Authors:  Ewelina Dondajewska; Wojciech Juzwa; Andrzej Mackiewicz; Hanna Dams-Kozlowska
Journal:  Oncotarget       Date:  2017-12-22

Review 5.  A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response.

Authors:  Marcella Regina Cardoso; Juliana Carvalho Santos; Marcelo Lima Ribeiro; Maria Cecília Ramiro Talarico; Lais Rosa Viana; Sophie Françoise Mauricette Derchain
Journal:  Int J Mol Sci       Date:  2018-02-21       Impact factor: 5.923

Review 6.  Metabolic Reprogramming in Triple-Negative Breast Cancer.

Authors:  Xiangyu Sun; Mozhi Wang; Mengshen Wang; Xueting Yu; Jingyi Guo; Tie Sun; Xinyan Li; Litong Yao; Haoran Dong; Yingying Xu
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

Review 7.  Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer.

Authors:  Roberto Corchado-Cobos; Natalia García-Sancha; Marina Mendiburu-Eliçabe; Aurora Gómez-Vecino; Alejandro Jiménez-Navas; Manuel Jesús Pérez-Baena; Marina Holgado-Madruga; Jian-Hua Mao; Javier Cañueto; Sonia Castillo-Lluva; Jesús Pérez-Losada
Journal:  Cancers (Basel)       Date:  2022-01-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.